Health Canada Approves Biocon's Denosumab Biosimilars for Osteoprosis, Cancer-Related Bone Conditons

Apr 21, 2026

Global biopharmaceutical company Biocon Limited on Tuesday said Health Canada has granted a Notice of Compliance for its biosimilar Bosaya and Vevzuo, both denosumab-based...